Clinical & Payment Policies
Clinical Policies
Clinical policies are one set of guidelines used to assist in administering health plan benefits, either by prior authorization or payment rules. They include but are not limited to policies relating to evolving medical technologies and procedures, as well as pharmacy policies. Clinical policies help identify whether services are medically necessary based on information found in generally accepted standards of medical practice; peer-reviewed medical literature; government agency/program approval status; evidence-based guidelines and positions of leading national health professional organizations; views of physicians practicing in relevant clinical areas affected by the policy; and other available clinical information.
All policies found in the Nebraska Total Care Clinical Policy Manual apply to Nebraska Total Care members. Policies in the Nebraska Total Care Clinical Policy Manual may have either a Nebraska Total Care or a “Centene” heading. Nebraska Total Care utilizes InterQual® criteria for those medical technologies, procedures or pharmaceutical treatments for which a Nebraska Total Care clinical policy does not exist. InterQual is a nationally recognized evidence-based decision support tool. You may access the InterQual® SmartSheet(s)™ for Adult and Pediatric procedures, durable medical equipment and imaging procedures by logging into the secure provider portal or by calling Nebraska Total Care. In addition, Nebraska Total Care may from time to time delegate utilization management of specific services; in such circumstances, the delegated vendor’s guidelines may also be used to support medical necessity and other coverage determinations. Other non-clinical policies (e.g., payment policies) or contract terms may further determine whether a technology, procedure or treatment that is not addressed in the Clinical Policy Manuals or InterQual®criteria is payable by Nebraska Total Care.
If you have any questions regarding these policies, please contact Member Services and ask to be directed to the Medical Management department.
| Policy Title | Policy Number | Effective Date |
|---|---|---|
| Asenapine (Saphris®) (PDF) | NE.PMN.15 | 01/01/2017 |
| Botulinum Toxins (PDF) | NE.PHAR.15 | 01/01/2017 |
| Brexpiprazole (Rexulti) (PDF) | NE.PMN.68 | 01/01/2017 |
| Bevacizumab (Avastin, Mvasi) (PDF) Effective 12/01/2011 - 3/31/2017 |
CP.PHAR.93 | Effective 12/01/2011 - 3/31/2017 |
| Bevacizumab (Avastin, Mvasi) (PDF) Effective 4/1/2017 - 12/31/2019 |
CP.PHAR.93 | Effective 4/1/2017 - 12/31/2019 |
| Bevacizumab (Avastin, Mvasi) (PDF) Effective 01/01/2020 |
CP.PHAR.93 | Effective 01/01/2020 |
| clobazam (Onfi®) (PDF) | NE.PMN.54 | 01/01/2017 |
| Clozapine ODT (Fazado®) (PDF) | NE.PMN.12 | 01/2017 |
| HER2 Breast Cancer Treatment (PDF) | NE.PHAR.67 | 01/01/2017 |
| Iloperidone (Fanapt®) (PDF) | NE.PMN.32 | 01/01/2017 |
| Linezolid (Zyvox) (PDF) | NE.PMN.27 | 01/01/2017 |
| lurasidone (Latuda®) (PDF) | NE.PMN.50 | 01/01/2017 |
| paliperidone ER (Invega®) (PDF) | NE.PMN.30 | 01/01/2017 |
| Paclitaxel, Protein Bound (Abraxane) (PDF) Effective 07/01/2015 - 09/30/2019 |
CP.PHAR.176 | Effective 07/01/2015 - 09/30/2019 |
| Paclitaxel, Protein Bound (Abraxane) (PDF) Effective 10/01/2019 |
CP.PHAR.176 | Effective 10/01/2019 |
| sodium oxybate (Xyrem®) (PDF) | NE.PMN.42 | 01/01/2017 |
| tedizolid (Sivextro®) (PDF) | NE.PMN.62 | 01/01/2017 |
Payment Policies
Health care claims payment policies are guidelines used to assist in administering payment rules based on generally accepted principles of correct coding. They are used to help identify whether health care services are correctly coded for reimbursement. Each payment rule is sourced by a generally accepted coding principle. They include, but are not limited to claims processing guidelines referenced by the Centers for Medicare and Medicaid Services (CMS), Publication 100-04, Claims Processing Manual for physicians/non-physician practitioners, the CMS National Correct Coding Initiative policy manual (procedure-to-procedure coding combination edits and medically unlikely edits), Current Procedural Technology guidance published by the American Medical Association (AMA) for reporting medical procedures and services, health plan clinical policies based on the appropriateness of health care and medical necessity, and at times state-specific claims reimbursement guidance.
All policies found in the Nebraska Total Care Payment Policy Manual apply with respect to Nebraska Total Care members. Policies in the Nebraska Total Care Payment Policy Manual may have either a Nebraska Total Care or a “Centene” heading. In addition, Nebraska Total Care may from time to time employ a vendor that applies payment policies to specific services; in such circumstances, the vendor’s guidelines may also be used to determine whether a service has been correctly coded. Other policies (e.g., clinical policies) or contract terms may further determine whether a technology, procedure or treatment that is not addressed in the Payment Policy Manual is payable by Nebraska Total Care.
If you have any questions regarding these policies, please contact Member Services and ask to be directed to the Medical Management department.